1Department of Infectious Diseases and Clinical Microbiology, İstanbul
2Department of Hematology, İstanbul
*Corresponding author: Habip Gedik, Department of Infectious Diseases and Clinical Microbiology, Istanbul
Submission: February 02, 2022; Published: March 28, 2022
ISSN: 2578-0190 Volume5 Issue5
Objective: It was aimed to retrospectively examine the clinical and survival results of patients who were
consulted with the hematology clinic due to hematological disorders related to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2).
Materials and methods: In this study, the data of patients who were hospitalized and consulted to the
hematology clinic due to hematological disorders related to COVID-19 infection diagnosed by radiological
findings and/or PCR results in the Ministry of Health Istanbul Training and Research Hospital between
April 1 2020 and May 21 2020, were evaluated, retrospectively.
Results: Of the 48 patients evaluated in the study, 25 (52%) were female and 29 (60%) were 60 years old
and above. Leukocytosis in 5(10%) patients, leukopenia in 19 (39%) patients, and D-Dimer ≥2ng/mL
and Ferritin ≥500ml/ng in 32(66%) patients were remarkable. D-Dimer was found to be ≥2ng/mL and
Ferritin ≥500ml/ng in 9 out of 10 patients in intensive care. A total of seven (14%) patients died.
Conclusion: Patients who are over the age of 60, and have lymphocyte count <1000μl/ml, D-Dimer value
above 2ng/mL, and ferritin over 500ml/ng are more likely to need a follow-up in the intensive care. For
this reason, vaccination of people over the age of 60, moreover, the high antibody response obtained with
the vaccine seems to be the most important precaution that can be taken against this disease.
Keywords:COVID-19; SARS-CoV-2; Gender; Hematology; Lymphopenia; Thrombocytopenia; Survival; Intensive care; D-dimer; Ferritin